Myriad advances in all fields of cardiac imaging have stimulated and reflected new understanding of cardiac performance, myocardial damage and the mechanisms of heart failure. In this paper, the Heart Failure Association assesses the potential usefulness of innovative imaging modalities in enabling more precise diagnostic and prognostic evaluation, as well as in guiding treatment strategies. Many new methods have gradually penetrated clinical practice and are on their way to becoming a part of routine evaluation. This paper focuses on myocardial deformation and three-dimensional ultrasound imaging; stress tests for the evaluation of contractile and filling function; the progress of magnetic resonance techniques; molecular imaging and other sound innovations.
Introduction
Recent innovations in cardiac imaging are rapidly entering the clinical arsenal of diagnostic and prognostic tools for both subclinical stage and overt heart failure (HF). Novel image acquisition strategies, advanced reconstruction techniques, conversion of analogue to digital signal processing and image storage, improvements in transducer technology and automated border detection are facilitating improved image quality, more accurate quantification, reduction in examination time and truly three-dimensional (3D) dynamic acquisitions.
The Heart Failure Association (HFA) seeks to acknowledge and highlight the exciting new developments taking place in the assessment of cardiac morphology, physiology, perfusion and tissue characterization of the myocardium. The growing diagnostic and prognostic utility of 3D and myocardial deformation imaging enriches the capabilities of a comprehensive examination, extending the evaluation of volumes and function to all cardiac chambers. Advances in the understanding of the pathophysiology of myocardial architecture and mechanics that conceptualize the HF syndrome are transformative and introduce novel imaging biomarkers. Global longitudinal strain (GLS), 3D volumes, and measurements of the extracellular compartment expand potential surrogate endpoints for clinical care and research, regardless of the mechanism of cardiac remodelling.
Recent HF guidelines from the European Society of Cardiology recommend the use of myocardial strain for the early detection of cardiac dysfunction, as well as late gadolinium enhancement (LGE) for the aetiologic differentiation of HF syndromes. 1 In this current document, the HFA aims to promote further awareness of imaging innovations which have the potential to revolutionize the field of diagnosis and decision making in HF ( Figure 1) . Therefore, the readers will find in this document not only clinically established techniques, but also those early data that appear to be promising for future clinical applicability and/or provide conceptual novelty ( 
Shifting the paradigm from two-dimensional echocardiography to better volumetric and deformation assessment by three-dimensional echocardiography
Revolutionary real-time 3D echocardiography (RT3DE) probably is the most accurate method of assessing left and right ventricular ejection fraction and correlates well with cardiac magnetic resonance (CMR) if image quality is good 2 -4 ( Figure 2 ). Recent technological progress together with fully automated software 5 makes RT3DE a user-friendly technique with adequate spatial and temporal resolution. Human border verification and manual editing of endocardial contours further improve accuracy of automated computed algorithms based on artificial intelligence and pattern recognition. Reference values of ventricular volumes and ejection fractions, as well as for atrial volumes have recently been published. 6 Contrast administration on 3D echocardiography results in improved determination of left ventricular (LV) volumes and reduced inter-reader variability. 7, 8 (More studies reporting validation, reference values and use of innovative vs. conventional imaging techniques are listed in the online supplementary Table S1 ).
Due to its reproducibility, and because it overcomes geometric assumptions and foreshortening, RT3DE is preferred over two-dimensional (2D) echocardiography for the assessment of candidacy for therapeutic device implantation. 9 It is also recommended as the technique of choice for monitoring of the cardiac effects of chemotherapy.
10
Three-dimensional speckle-tracking echocardiography, validated in animal models against sonomicrometry, CMR and 2D speckle tracking, 11 holds great promise for further quantification of LV and right ventricular (RV) function. Unlike 2D imaging, speckles remain visible within the pyramidal volume scan; this circumstance made it possible to put forward a hypothesis that despite considerably lower frame rates, inherent to current 3D imaging, ultrasound speckles can be tracked in 3D space without the risk of being lost as they always remain in the 3D field of view. Consequently, it was shown that 3D deformation assessment is not undermined in comparison with 2D if the temporal resolution remains at least 18-25 Hz. At the same time, it is expected that advances in ultrasound beam forming and possibilities of ultrafast image acquisition will significantly improve temporal resolution of 3D speckle tracking and depiction of short-lived mechanical events. In addition, a new concept of endocardial area tracking combining two strain directions is proposed. Area strain as a measure of the change in surface area of a given myocardial segment may appear as one of the most sensitive markers of early cardiac dysfunction. Several studies provide normal ranges for 3D strain values highlighting certain age-and gender-specificity. 12, 13 Reduction in the values of the global longitudinal, circumferential and area strain positively correlate with elevated LV filling pressure in patients with preserved 3D LV ejection fraction (LVEF).
Recent studies of myocardial architecture represent the left ventricle as having double endocardial and epicardial helical arrangement with opposite rotation of LV base and apex during systolic twist and diastolic untwisting.
14 Three-dimensional deformation imaging allows accurate and reproducible quantification of LV twist mechanics providing correct location of basal and apical plane and overcoming limitations of 2D speckle tracking. The increase of LV twist indicates compensatory stages of HF with preserved ejection fraction (HFpEF) and chronic LV afterload, while delayed untwisting plays a role in diastolic dysfunction.
Three-dimensional speckle tracking can help identify the aetiology of HF; in small series of patients with cardiac amyloidosis (online supplementary catheter-based procedural planning as it allows assessment of valve, vessel and chamber function and volumes: RT3DE enables delivery and study of percutaneous intervention, including transcatheter aortic valve implantatiom and MitraClip, potentially increasing the likelihood of a successful outcome.
Finally, patient-specific 3D-printed models support more comprehensive understanding of unique geometry and enhanced structures in pre-procedural planning before left ventricular assist device implantation in complex anatomical cases (Figure 3 ) 15 or valve surgery ( Figure 4) . Interactive 3D holograms based on live 3D transoesophageal echocardiography may be the future in real-time imaging.
Key points
• Three-dimensional echocardiography has superior accuracy and is thus the preferred method for volumetric assessment of cardiac chambers.
• Automated or semi-automated endocardial contouring method ensures the highest convenience and reproducibility of 3D echocardiography.
• As technology advances, 3D strain should integrate and simplify evaluation of 3D ventricular deformation, including twist. 20 Still, it should be noted that in one third of study patients invasive and echocardiographic measurements did not match, predominantly in those with preserved LVEF. Lately, the application of the machine learning algorithm to a database derived from speckle-tracking echocardiography has been suggested to develop an automated assessment of diastolic function.
Shifting the paradigm from ejection fraction to a new assessment of myocardial mechanics
A better understanding of ventricular performance indicates that the longitudinal function is the main contributor to the generation Figure 3 Workflow associated with creating a three-dimensional (3D) cardiac model. A sample of workflow is shown diagrammatically from identification of adults with congenital heart disease and heart failure (ACHD-HF) to image acquisition and creation of a virtual and 3D printed solid model. This model is used by the cardiac and surgical teams for pre-procedural planning before ventricular assist device (VAD) placement. d-TGA, dextro-transposition of the great arteries; l-TGA, levo-transposition of the great arteries. Reprinted with permission from Farooqi et al. 15 of stroke volume in healthy subjects, as well as in patients with myocardial infarction and dilated cardiomyopathy. Recent study on the geometrical determinants of ejection fraction and myocardial deformation showed that ejection fraction could remain unaltered despite significantly reduced LV function defined as a decrease in longitudinal and circumferential shortening (online supplementary  Table S1 , ref. no. e43). GLS probably is the most robust deformation marker, detecting alterations in myocardial mechanics with and without LV dilatation. This novel parameter of myocardial shortening from base to apex is superior to ejection fraction in the detection of early cardiac dysfunction in the general population, in the diagnosis of HFpEF, in the evaluation of chemotherapy-induced cardiotoxicity and in valvular heart disease. 21 -24 In a healthy person, value of a peak GLS can be expected in the range of -20%. 6, 9 Further, EACVI/American Society of Echocardiography (ASE)/Industry initiative has been taken to standardize deformation imaging platforms across vendors in order to reduce inter-vendor variability measurements. 25 The improvement of concordance has . been achieved due to homogenizing of post-processing and strain algorithms in proprietary software packages, including the location of the region of interest, the degree of smoothing and details of strain processing. 25 The CMR feature-tracking (CMR-FT) technique is based on the recognition of edges, tracked in successive frames, and allows deformation assessment of all cardiac chambers. CMR strain measurement has been shown to quantify dyssynchrony and predict risk in patients with non-ischaemic cardiomyopathy ( Figures 5 and 6 ). Cardiac CT as well could be used to determine myocardial strain via a mathematical algorithm, devised to calculate both strain and rotational dynamics within a normal CT dataset. This novel technique was validated against speckle tracking.
Importantly, GLS correlates better than LVEF with myocardial fibrosis, focal and diffuse, as detected on CMR imaging. 26 Strain imaging can also be very effective in differentiating between specific causes of myocardial hypertrophy (Figures 7 and 8 ; online supplementary Figure S1 ) demonstrating typical regional patterns in amyloidosis ( Figure 9 ), athlete's heart, hypertrophic ( Figure 10 ), ischaemic cardiomyopathy ( Figure 11 ) and other pathologies ( Figure 12 ; online supplementary Figure S2 ). 27 In the DIG trial, the greatest predictive value of LVEF was shown only in moderately and severely impaired ventricles and was lost in LVEF > 45% (online supplementary Table S1 , ref. no. e23). A number of observational and interventional studies, in a variety of HF aetiologies, has demonstrated GLS to be superior to both LVEF and filling parameters in predicting outcome ( Table 2) .
5,28 -32 Further, a large systematic review comprising 5721 adults with HF, acute myocardial infarction, valvular and miscellaneous cardiac diseases also found that GLS was a better prognosticator of outcome compared to LVEF. 28 In the TOPCAT study, impaired longitudinal strain, defined as < 15.8%, was the strongest echocardiographic predictor of the composite outcome (online supplementary Table S1 , ref. no. e41). Moreover, LV systolic dysfunction determined using a GLS cut-off of -14.7% was a powerful and independent predictor of cardiovascular events in subjects with normal LVEF in a community-based cohort, thus being associated with better risk stratification than that based only on LVEF (online supplementary (Figure 13 ; online supplementary Figure S3 ) in pilot studies appears to be a predictor of arrhythmic events independent of LVEF. 33 Increased ventricular mechanical dispersion has been linked to malignant arrhythmias in many underlying pathologies. 34 Preliminary data show that in patients with severe LV dysfunction, speckle-tracking technology can help guide placement of LV lead for resynchronization therapy by identifying the most delayed (time to peak radial strain) but non-scarred (segmental radial strain > 10%) LV myocardial segment, 35 -38 though larger prospective randomized studies are warranted.
Novel non-invasive methods to assess regional myocardial work by utilizing LV pressure-strain loop corresponds well with invasive measurements and myocardial metabolic demand, promising further insights into mechanisms of LV dyssynchrony, ischaemia and remodelling. Based on measuring brachial blood pressure, the reference pressure loop, the timing of aortic and mitral valve events and speckle tracking, the forthcoming semi-automated software will be able to calculate and present the regional myocardial work in a parametric manner.
Additional applications of deformation imaging include functional evaluation of the remaining cardiac chambers: left atrium and right ventricle. The measurement of left atrial strain by ultrasound or CMR reflects reservoir, conduit and pump function, left atrial stiffness, and mean wedge pressure. 39 Speckle tracking-derived left atrial GLS provides incremental information on the existence of paroxysmal atrial fibrillation and prediction of major embolic and cardiovascular events. Study of the MESA cohort found that decline in left atrial function over time as measured by CMR-FT was independently associated with the development of HF. Early data indicate that amongst echocardiographic parameters of RV function, longitudinal strain best correlates with right ventricular CMR imaging-determined ejection fraction (online supplementary Figure S4 ) and predicts RV failure after assist device implantation. 40 Finally, the uniform training and standardization of deformation assessments is an imperative to facilitate accuracy and subclinical disease detection, as has been proposed in a multicentre trial studying the incremental value of myocardial strain for the detection of cardiotoxicity. The sharing of interpretations, personalized feedback especially on the width and location of the region of interest and adequacy of tracking significantly reduced the variation in inter-institutional strain measurements.
Key points
• The estimation of ejection fraction is meaningful with concomitant report of ventricular end-diastolic and stroke volume.
• Routine assessment of diastolic dysfunction and LV filling pressure should be performed according to the 2016 EACVI/ASE recommendations.
• Inclusion of GLS in the assessment of established or suspected HF adds considerable diagnostic and prognostic value.
• Characteristic regional strain patterns help to differentiate causes of LV hypertrophy. 
Shifting the paradigm from rest to stress assessment of left ventricular function
Functional cardiac imaging assessment at rest will often not correlate with exertional HF symptoms. Stress echocardiography allows assessment of LV systolic and diastolic functional reserve, as well as detection of pulmonary congestion in patients with known or suspected HF. Echocardiographic estimation of LV filling pressure and systolic pulmonary artery pressure at low workload exercise (before heart rate-related fusion of E and A waves) can unmask a diagnosis of HFpEF 41 ( Figure 14) . In healthy subjects, there is proportional increase in both mitral inflow and annular velocities during exercise, leading to an unchanged E/e' ratio without pathologic increase in estimated systolic pulmonary artery pressure from the tricuspid regurgitant velocity; the average (or septal) E/e' ratio remains < 10 and the peak tricuspid regurgitant velocity < 2.8 m/s.
Conversely, in HFpEF, myocardial relaxation does not augment on exercise; maintenance of adequate cardiac output is achieved at the expense of increased LV filling pressure. Exercise echocardiography is currently recommended for diagnosis of diastolic dysfunction with a threshold of average E/e' > 14, septal E/e' ratio > 15 and peak tricuspid regurgitant velocity > 2.8 m/s. 41 .
There is good correlation between E/e' and invasive LV diastolic pressure at variable levels of effort on supine bicycle exercise in the catheterization laboratory 42 ; invasive assessment revealed substantially worse prognosis in HFpEF patients with excessive rise of pulmonary capillary wedge pressure during exercise (28% rate of 10-year mortality vs. 7% in case of normal exercise wedge pressure).
The demonstration of vertical laser-like B-lines with lung ultrasound during exercise echocardiography, arising from the pleural line and moving with respiration, may help explain exertional dyspnoea as being due to interstitial congestion. 43 Being a semi-quantitative sign of extravascular lung water, B-lines are present in one third of HF patients at rest and in one of two during stress. 44 The potential of this easily obtainable sign for refining the risk stratification should be determined in an ongoing multicentre trial. 44 In dilated non-ischaemic cardiomyopathy, the presence of contractile reserve, detected by improved wall motion score, LVEF and longitudinal strain during stress, is associated with increased survival, improved response to medical and device therapy, and inverse correlation with degree of interstitial fibrosis. An increase in LVEF by ≥ 7.5% on exercise identified responders to cardiac resynchronization therapy. Conversely, the absence of contractile reserve was a marker of poor prognosis. Circumferential strain is abnormal with a mild/moderate reduction in the middle and apical levels of the left ventricle up to lengthening (instead of shortening) at the basal septum. An international multicentre study has been designed to investigate the value of innovative applications of stress echocardiography in HF. 41 Study parameters include the load-independent index of LV elastance reserve, defined as the peak stress/baseline ratio of end-systolic pressure/end-systolic volume, which has been proposed as a more specific measure of cardiac performance than changes in ejection fraction.
Key points
• Diastolic stress test is recommended when diastolic dysfunction on exercise is considered, to confirm the diagnosis of HFpEF. • Lung ultrasound during stress detects interstitial congestion to explain symptoms and potentially refine HF risk stratification.
• Existence of contractile reserve during stress can predict response to therapy and a better prognosis in HF patients.
Shifting the paradigm from late gadolinium enhancement to deeper tissue characterization
Late gadolinium enhancement imaging in CMR has an established role since finding such enhancement can be both diagnostic and prognostic in several disease processes. 46, 47 Preliminary data have found that a single-breath-hold 3D acquisition technique enables quantitative evaluation of scar tissue mass, significantly reducing the significant left ventricular dysfunction with regional abnormalities resembling coronary territory. EF, ejection fraction; GS, global strain. Correlation with CMR LVEF 2D LVEF r = 0. 58 . 3D LVEF r = 0.80, P < 0.000
Longitudinal reproducibility Temporal variability of non-contrast 3D echocardiographic LVEF 5.6%, 2D echocardiographic LVEF 9.8% No significant temporal variability 2D, two-dimensional; 3D, three-dimensional; CMR, cardiac magnetic resonance; GLS, global longitudinal strain; HF, heart failure; HFmrFF, heart failure with moderately reduced ejection fraction; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; LV, left ventricular; LVEF, left ventricular ejection fraction; MI, myocardial infarction. examination time for LGE CMR imaging. It has potential application in those with implantable devices and complex cardiac anatomy and can be undertaken at much shorter breath-holds.
Cardiac magnetic resonance T2* was the first of the quantitative measurements of relaxation properties to have significant clinical impact. T2* is altered by local variations in the homogeneity of the magnetic field caused by intracellular iron deposits which reduce T2*. 48 Since development of practical T2* measurements, mortality from HF in patients with thalassaemia improved markedly; CMR T2* predicts the likelihood that patients with thalassaemia develop HF and arrhythmias. In acute myocarditis and Takotsubo cardiomyopathy, quantitative T1 and T2 mapping accurately identifies extent of myocardial involvement 49 ; additionally, T2 mapping has a potential to monitor myocardial oedema and decongestion in acute HF.
T1 mapping is an emerging CMR technique that involves the creation of a pixelated map obtained by measuring the longitudinal relaxation time of individual protons whilst they re-equilibrate following excitation with the radiofrequency beam. Importantly, this novel method enables to quantify the extracellular volume (ECV) fraction of myocardium, which reflects diffuse changes such as fibrosis, interstitial oedema, deposition of proteins, lipids, . Post-contrast and native T1 mapping allows assessment of expansion of the interstitium not detectable by conventional delayed enhancement and has been histologically validated in HF patients. Progressive shortening of T1 time was observed along with the deterioration of diastolic function illuminating a potential mechanistic link. A significant correlation between myocardial ECV and LV volumes, ejection fraction, peak ejection and peak filling rate was shown uniquely in HFpEF patients in contrast to the absence of similar associations in HF with reduced ejection fraction. 51 Diffuse myocardial fibrosis was detected in hypertrophic cardiomyopathy (HCM) patients with no association found between the amount of LGE and post-contrast myocardial T1 time, indicating that diffuse and regional fibrosis might be disparate entities (online supplementary Figure 13 Example of low (A) and higher (B) mechanical dispersion on longitudinal strain curves from 4-chamber views of two different patients. The vertical red arrows at the bottom indicate the earliest and the latest peak negative strain in the six strain curves from the six segments of the left ventricle. It is evident that the strain curves in the right example are less synchronous (more dispersed) than those on the left side. Dispersion can be quantified as the standard deviation of time-to-peak negative strain (see green double arrow on the left as example of time-to-peak negative strain of the green strain curve) from all longitudinal strain curves from all three apical views.
Figure 14
Diastolic stress echocardiography: E, septal E' and lateral E' at baseline, 25 W and 50 W in a patient with shortness of breath on exertion during supine bicycle exercise. There is progressive rise in E/E' ratio, using both average and septal E'. The test was stopped because of shortness of breath at 50 W (low workload).
for the detection of adverse tissue remodelling at early stages of hypertensive, diabetic and other diffuse heart diseases justifies its use in the evaluation of novel treatments, for example, antifibrotic therapies. 53 A significant relationship between ECV and mortality as well as worsening of HF was demonstrated in a wide cohort of cardiac patients, exceeding the predictive value of LGE. 54 These early findings underscore the biologic importance of extracellular . matrix expansion, which seems to be modifiable and can become a treatment target. Elevated myocardial T1 times are typical in both amyloid light-chain (AL) and transthyretin (ATTR) amyloidosis, correlate with markers of systolic and diastolic function, mass, and may represent a direct marker of cardiac amyloid load (Figure 15) . Interestingly, lower T1 prolongation was documented in ATTR Figure 15 Cardiac magnetic resonance multi-parametric assessment of a normal heart and cardiac amyloidosis. Top row: Amyloid light-chain (AL)-amyloidosis, short axis cine view with abnormally thickened walls (left), diffuse increase in myocardial T1 time on native T1 mapping (middle) and pronounced subendocardial late gadolinium enhancement (LGE) in the septum with transmural LGE in the inferior wall (right). Bottom row: Healthy control, short axis cine view with normal thickness of the myocardium (left), normal native T1 values (middle) and no LGE. SSFP-cine, steady state free precession magnetic resonance imaging. compared with AL type, and T1 tracking was more sensitive in gene mutation carriers than LGE imaging for early diagnosis (online supplementary Table S1 , ref. no. e104).
Non-contrast T1 mapping was shown to be a powerful modality in the diagnostic workup of LV hypertrophy (Figure 16) , 55 discriminating Anderson-Fabry from HCM, hypertension, aortic stenosis and amyloidosis without overlap. Low T1 with no LV hypertrophy was found in 40% of Anderson-Fabry affected subjects, implying the possibility of early disease detection in those with greatest potential to benefit from enzyme replacement therapy (online supplementary Table S1 , ref. no. e101). Moreover, ECV quantification is feasible by dynamic equilibrium cardiac CT and has significant potential in the diagnosis and quantification of cardiac amyloidosis. Recent consensus 55 recommends consideration of parametric mapping in the diagnostic evaluation of all HF patients for state-of-the-art tissue characterization. However, it should be noted that due to the variety of acquisition schemes, field strengths and post-processing methods used both between institutions and vendors, the reproducibility of absolute T1 values is limited but is better for ECV values that take individual patient characteristics into account.
Diffusion tensor CMR (DT-CMR) can infer the microstructure of the myocardium by assessing the diffusion of water and, as such, provides a novel way of phenotyping cardiac disease at a cellular level. DT-CMR displays the helical arrangement of myocytes and the orientation of sheetlets (aggregates of myocytes), which cyclically realign from wall-perpendicular in diastole to wall-parallel . in systole in healthy subjects ( Figure 17 ). As such, sheetlet dynamics can be studied to give new insights into differing disease states and mechanisms of dysfunction. Aberrant sheetlet orientation and reduced sheetlet mobility have been shown in both dilated cardiomyopathy 56 and HCM (online supplementary Table S1 , ref.
no. e108).
Radiomics represents a current field of radiological research being characterized by conversion of imaging data into a highly dimensional mineable feature space generated by automatic data characterization algorithms. Handling large amounts of data (big data) requires new, non-conventional statistical approaches, therefore novel machine learning algorithms have recently been introduced. A recent study showed that certain texture analysis features identified by machine learning algorithms allow to diagnose subacute and chronic myocardial infarction on non-contrast enhanced CMR images, even though no signal abnormalities could be visually demarcated (online supplementary Table S1 , ref. no. e120). Lastly, computational flow dynamics can be combined with CMR to enable detailed characterization of patient-specific physiological pressure and flow metrics.
Key points
• T1 mapping provides the possibility of assessing and quantifying expansion of the interstitium, typical for early stages of HFpEF and specific infiltrative diseases. • T1 times correlate better with 2D longitudinal strain than with LVEF.
• T1 mapping is a useful tool in diagnostic workup of LV hypertrophy, discriminating specific aetiologies of HF.
Shifting the paradigm from morphometry and function to imaging of pathogenetic mechanisms
Molecular imaging is a rapidly expanding field with the potential to facilitate the targeted study of pathological cardiac remodelling and HF. Molecular tracers mirror the pathophysiology of disease correlating to the events at the molecular level such as fibrosis, apoptosis, remodelling of extracellular matrix. for imaging of inflammation in acute myocarditis using spectral CT with late iodine enhancement. 57 Magnetic resonance imaging combined with fluorescence tomography offers a unique possibility to visualize myocardial macrophage infiltration in vivo. 58 Furthermore, CMR allows tracking of retention and engraftment of magnetically labelled mesenchymal stem cells. 59 A novel technique of hyperpolarized carbon or nitrogen magnetic resonance spectroscopy enables the near real-time sensitive and non-invasive assessment of metabolic alterations.
Single photon emission computed tomography (SPECT) using the tracer 123 I-MIBG (iodine-metaiodobenzylguanidine) allows the scintigraphic assessment of the sympathetic nervous system and as such offers insight into the neurohormonal activation of a failing heart 60 ; published work has shown that use of this tracer to determine sympathetic activity has been predictive of HF hospitalization and all-cause cardiovascular mortality (online supplementary Table S1 , ref. no. e131). On this premise, assessment of sympathetic nervous system hyperactivation using a blood marker proxy [myocardial G protein-coupled receptor kinase-2 (GRK2)] was shown to independently predict outcome in those with chronic HF. 61 Positron emission tomography (PET) imaging using a radiolabelled catecholamine shows promise in terms of assessing perfusion/innervation mismatch as a substrate for post-infarct ventricular tachycardia. The measurement of LV synchrony by registering homogeneity of cardiac adrenergic activity by 11 C-hydroxyephedrine PET/CT suggests predictor of response to cardiac resynchronization therapy (online supplementary Table  S1 , ref. no. e130).
Hybrid imaging offers a superb anatomical presentation merged with a wide array of molecular tracers, which enables to track molecular changes and processes to specific areas in the heart. Recent phantom research promises that combination of CMR/PET scanners will allow simultaneous CMR and PET metabolic imaging with the applications for perfusion, characterization of tissue cellularity and metabolites. A unique concept of concomitant measuring myocardial work by means of CMR strain and myofibre stress with estimation of oxygen utilization by PET allows calculation of cardiac efficiency. 62 PET imaging is established in the identification of active sarcoidosis, including cardiac involvement. Published data suggest that this imaging modality may also be helpful for diagnosis and differentiating the type of cardiac amyloid (Figure 18 ) 63 .
Key points
• Molecular tracers promise to facilitate imaging of specific culprits of the disease such as fibrosis, apoptosis, inflammation, metabolic alterations, as well as targeted therapies such as cell retention and engraftment. • Hybrid CMR/PET imaging allows to calculate cardiac efficiency by simultaneous imaging of myocardial strain and stress and oxygen utilization.
Shifting the paradigm from invasive to novel non-invasive assessment of coronary anatomy and perfusion
Because about half of the cases of HF has ischaemic origin, 64 an accurate assessment of coronary anatomy and myocardial perfusion is required. 65 A recent meta-analysis showed superior diagnostic accuracy of rubidium-82 PET over stress-rest SPECT in the detection of obstructive coronary artery disease (CAD) (online supplementary Table S1 , ref. no. e138). PET additionally provides absolute data on myocardial blood flow and reserve that may aid in assessing the physiologic significance of intermediate stenosis, multivessel and small-vessel disease. Further, the extension of myocardial blood flow reserve impairment is a powerful prognostic parameter in patients with ischaemic 66 and non-ischaemic HF. Hybrid PET and SPECT/CT, PET/CMR combining anatomical and functional information have been found to have greater sensitivity and specificity for the diagnosis of CAD and higher prognostic power than either modality alone.
Cardiac magnetic resonance perfusion is an excellent method for the investigation of CAD, however attempts are ongoing to increase the spatial and temporal resolution by accelerated perfusion imaging. 3D CMR perfusion imaging is a novel alternative with several advantages on standard 2D approaches: it allows imaging of the entire myocardium with more accurate quantification of the degree of myocardial ischaemia and facilitates higher signal-to-noise ratio and contrast-to-noise ratio.
The combination of F-18 fluorodeoxyglucose ( 18 FDG), reflecting glucose metabolism, and 13 N-ammonia, reflecting blood flow, is used to distinguish between necrotic and viable myocardium in HF. In parallel, the integration of FDG uptake in PET with LGE and T2 mapping in CMR have the potential to improve prediction of viability after revascularization and provide further insights into the pathophysiology of post-myocardial infarction LV remodelling.
Multi-detector CT is well established in the delineation of coronary artery anatomy and obstruction, allowing discrimination between ischaemic and non-ischaemic cardiomyopathy in a non-invasive manner. Further, CT can satisfactorily visualize and measure infarct size, with good correlations reported with CMR. 67 This ensures that CT is a valuable alternative to CMR when this is either unavailable or contraindicated. Latest generation CT scanners allow the acquiring of high-quality images using a smaller amount of iodinated contrast whilst application of acquisition protocols using prospective ECG gating enables reduction of scan time and radiation exposure.
Conventional static cardiac CT provides only anatomical data on the significance of CAD. Adenosine-stress dynamic myocardial CT perfusion imaging, however, is an evolving modality that can simultaneously assess anatomic and functional significance of a coronary 63 stenosis, and with the use of computational fluid dynamics even measure non-invasive fractional flow reserve (CT-FFR). Data suggest the dynamic assessment of myocardial perfusion with CT is comparable to that obtained with CMR and SPECT. CT-FFR has been validated against invasive FFR and has recently been approved for use in the U.S. 68 ; further, recent studies have found that CT-FFR may be a superior gatekeeper to invasive coronary angiography in those with stable chest pain as compared to CT anatomic assessment of coronary artery stenosis alone (online supplementary 
Key points
• Impairment of myocardial blood flow reserve evaluated by novel PET techniques predicts the prognosis in ischaemic and non-ischaemic HF.
• Combined nuclear imaging of glucose metabolism and myocardial blood flow improves the detection of viable myocardium.
• The use of computational fluid dynamics in CT allows to measure non-invasive coronary FFR. 
Conclusions
Rapid technological growth provides a wealth of information derived from cardiac imaging which can increasingly ameliorate HF therapy. 3D echocardiography provides better quantification of ventricular volumes, especially relevant in the fields of device implantation and cardio-oncology. Deformation imaging dramatically improves assessment of LV performance, yielding functional and prognostic information distinct from ejection fraction. Stress assessment of diastolic function, contractile reserve and pulmonary congestion facilitates early and accurate HF diagnosis and risk stratification, regardless of LVEF. Innovative magnetic resonance techniques have the advantage of deep characterization of extracellular matrix abnormalities, previously not amenable to visualization. Exciting nuclear and hybrid modalities expand the identification of myocardial disease to microvascular, cellular and molecular level. Lastly, the way we store, build and share databases of images in the Cloud will ensure easy access, globalization of information and favourable integrated workflow. Inclusion of novel cardiac imaging modalities into everyday practice will facilitate significant improvement of the quality of HF management.
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